These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2065506)

  • 21. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
    J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: an 8-week randomized controlled pilot study.
    Al-Gareeb AIA; Gorial FI; Mahmood AS
    Clin Rheumatol; 2018 Oct; 37(10):2633-2641. PubMed ID: 29882203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteocalcin in patients with rheumatoid arthritis. A one-year followup study.
    Franck H; Ittel TH; Tasch O; Herborn G; Rau R
    J Rheumatol; 1994 Jul; 21(7):1256-9. PubMed ID: 7966066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
    Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
    Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
    Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
    Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants.
    Inciarte-Mundo J; Ruiz-Esquide V; Hernández MV; Cañete JD; Cabrera-Villalba SR; Ramirez J; Yagüe J; Sanmarti R
    Rheumatology (Oxford); 2015 Dec; 54(12):2239-43. PubMed ID: 26242859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis.
    El Miedany YM; Abubakr IH; El Baddini M
    J Rheumatol; 1998 Nov; 25(11):2083-7. PubMed ID: 9818648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
    Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
    Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
    Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
    J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
    Ban A; Inaba M; Furumitsu Y; Okamoto K; Yukioka K; Goto H; Nishizawa Y
    Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of golimumab 100-mg monotherapy to golimumab 50 mg plus methotrexate in patients with rheumatoid arthritis: Results from a multicenter, cohort study.
    Yonemoto Y; Okamura K; Takeuchi K; Ayabe K; Kaneko T; Matsushita M; Tamura Y; Iso T; Okura C; Otsuka K; Inoue H; Takagishi K
    Mod Rheumatol; 2016; 26(1):24-8. PubMed ID: 26140464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Methylprednisolone Acetate Versus Triamcinolone Acetonide Intra-articular Knee Injection in Patients With Chronic Inflammatory Arthritis: A 24-Week Randomized Controlled Trial.
    Kumar A; Dhir V; Sharma S; Sharma A; Singh S
    Clin Ther; 2017 Jan; 39(1):150-158. PubMed ID: 28012569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Observation on effect of double filtration plasmapheresis on patients with active rheumatoid arthritis in active stage].
    Yu XX; Xu P; Gao P; Ma JR; Tian JG; Jiang SH; Ping LF; Gao N; Han HP; Wang LX
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):568-9. PubMed ID: 16146609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis.
    Warren MS; Hughes SG; Singleton W; Yamashita M; Genovese MC
    Arthritis Res Ther; 2015 Mar; 17(1):80. PubMed ID: 25885521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
    Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
    Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy.
    Ghang B; Kwon O; Hong S; Lee CK; Yoo B; Kim YG
    Mod Rheumatol; 2017 May; 27(3):405-410. PubMed ID: 27686747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis.
    Lerndal T; Svensson B
    Rheumatology (Oxford); 2000 Mar; 39(3):316-20. PubMed ID: 10788542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative sensitivity to change of the erythrocyte sedimentation rate and serum C-reactive protein concentration in rheumatoid arthritis.
    Ward MM
    J Rheumatol; 2004 May; 31(5):884-95. PubMed ID: 15124246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment of erythrocyte sedimentation rate (ESR) and C- reactive protein (CRP) on rheumatoid arthritis activity prediction].
    Silva I; Mateus M; Branco JC
    Acta Reumatol Port; 2010; 35(5):456-62. PubMed ID: 21245814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.
    Dessein PH; Joffe BI; Stanwix AE
    J Rheumatol; 2004 Jun; 31(6):1095-7. PubMed ID: 15170920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.